Justia Department Of Health And Human Services Centers For Disease Control And Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CK19-002, Quantifying Contact Rates and Mixing Patterns in Workers in Non-healthcare Work Settings in the United States; CK19-004, Study To Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD); and CK17-005SUPP, Vector-Borne Disease Regional Centers of Excellence, 14949 [2019-07265]

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CK19-002, Quantifying Contact Rates and Mixing Patterns in Workers in Non-healthcare Work Settings in the United States; CK19-004, Study To Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD); and CK17-005SUPP, Vector-Borne Disease Regional Centers of Excellence, 14949 [2019-07265]

Download as PDF Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices technicians, $20.59 (occupation code 29–2071). The average hourly rate of $53.69 for secondary data was calculated based on the 2017 mean hourly wage rate for medical and health services managers, $53.69 (occupation code 11–9111). Mean hourly wage rates for these groups of occupations were obtained from the Bureau of Labor & Statistics on ‘‘Occupational Employment and Wages, May 2017’’ found at the following URL: https://www.bls.gov/oes/current/oes_ nat.htm#b29-0000.htm. Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ’s health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Gopal Khanna, Director. grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–CE–19–006, Grants to Support New Investigators in Addressing CrossCutting Violence Prevention and Opioid Overdose Prevention. Date: June 11, 2019. Time: 11:00 a.m.–5:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F– 63, Atlanta, Georgia 30341, Telephone (770)488–6562, KLeeks@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–07266 Filed 4–11–19; 8:45 am] Centers for Disease Control and Prevention jbell on DSK30RV082PROD with NOTICES Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The VerDate Sep<11>2014 18:18 Apr 11, 2019 Jkt 247001 Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–07265 Filed 4–11–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES healthcare Work Settings in the United States; CK19–004, Study To Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD); and CK17–005SUPP, Vector-Borne Disease Regional Centers of Excellence; May 7, 2019; 10:00 a.m.— 5:00 p.m., (EDT) which was published in the Federal Register on March 15, 2019, Volume 84, Number 51, pages 9523. The meeting is being amended to remove CK17–005SUPP, Vector-Borne Disease Regional Centers of Excellence. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60, Atlanta, Georgia 30329, (404) 718–8833, gca5@ cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P Centers for Disease Control and Prevention [FR Doc. 2019–07303 Filed 4–11–19; 8:45 am] 14949 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CK19–002, Quantifying Contact Rates and Mixing Patterns in Workers in Non-healthcare Work Settings in the United States; CK19–004, Study To Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD); and CK17–005SUPP, Vector-Borne Disease Regional Centers of Excellence Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); CK19– 002, Quantifying Contact Rates and Mixing Patterns in Workers in Non- PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Communities Opioid Response Program Performance Measures, OMB No. 0906–xxxx, New Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR. SUMMARY: E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Page 14949]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07265]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CK19-002, Quantifying Contact Rates and Mixing 
Patterns in Workers in Non-healthcare Work Settings in the United 
States; CK19-004, Study To Assess the Risk of Blood Borne Transmission 
of Classic Forms of Creutzfeldt-Jakob Disease (CJD); and CK17-005SUPP, 
Vector-Borne Disease Regional Centers of Excellence

Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP); CK19-002, Quantifying Contact Rates and Mixing Patterns in 
Workers in Non-healthcare Work Settings in the United States; CK19-004, 
Study To Assess the Risk of Blood Borne Transmission of Classic Forms 
of Creutzfeldt-Jakob Disease (CJD); and CK17-005SUPP, Vector-Borne 
Disease Regional Centers of Excellence; May 7, 2019; 10:00 a.m.--5:00 
p.m., (EDT) which was published in the Federal Register on March 15, 
2019, Volume 84, Number 51, pages 9523.
    The meeting is being amended to remove CK17-005SUPP, Vector-Borne 
Disease Regional Centers of Excellence. The meeting is closed to the 
public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60, 
Atlanta, Georgia 30329, (404) 718-8833, [email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-07265 Filed 4-11-19; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.